ArticleFrontiers in pharmacology2025
Drug shortage in South Korea: machine learning-based prediction models and analysis of duration and causal factors.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Drug shortages remain a critical challenge for healthcare systems in South Korea. This study aimed to develop predictive models to forecast drug shortage duration and identify their underlying causes. Methods: Using 1,054 regulatory-reported drug shortage cases from 2018 to 2024 obtained from the Korean Ministry of Food and Drug Safety (KMFDS), we developed two machine learning models: (1) Model 1 to estimate shortage duration ranges, and (2) Model 2 to classify shortage causes into seven categories. Eighteen features related to drug shortages were included based on relevance and data availability. Key predictors were identified using Random Forest feature importance. Results: Model 1 achieved an accuracy of 62%, with Shortage Incidence Frequency being the most influential variable (importance = 0.152). In Model 2, weighted precision, recall, and F1-score all exceeded 70%, indicating robust performance despite imbalanced class distributions. The most important predictors for cause classification included Shortage Incidence Frequency, Existence of alternative drugs with the same ingredient, and Business size of the Marketing Authorization Holder. Conclusion: The KMFDS should continuously monitor drugs with repeated shortage episodes through regular reporting, early-warning systems, and supply-risk assessments. Incorporating supply-side indicators-particularly those related to economic feasibility-into national surveillance programs may help prevent shortages and mitigate their duration. By identifying key predictors associated with shortage causes, this study provides evidence to guide policy prioritization and targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.